You are here

Home / Resources / Key Material
Export 86 results:
Filters: First Letter Of Last Name is R  [Clear All Filters]
A
Kenawy, H. Ibrahim, Ali Y. Mohammed, Rajakumar K., Lynch N. J., Kadioglu A., Stover C. M., et al. (2012).  Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections. Immunobiology. 217, 272–280.
Rosete, D. P., Manjarrez M. Eugenia, & Barrón B. L. (2008).  Adenoviruses C in non-hospitalized Mexican children older than five years of age with acute respiratory infection. Memorias do Instituto Oswaldo Cruz. 103, 195–200.
Hazlett, L. D., Rosen D. D., & Berk R. S. (1978).  Age-Related Susceptibility to Pseudomonas aeruginosa Ocular Infections in Mice. Infection and Immunity. 20, 1.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Shepard, C.. W., Soriano-Gabarro M.., Zell E.. R., Hayslett J.., Lukacs S.., Goldstein S.., et al. (2002).  Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerging infectious diseases. 8, 10.
Pretzel, J., Mohring F., Rahlfs S., & Becker K. (2013).  Antiparasitic peptides. Yellow Biotechnology I. 157–192.
Rodrigues, E. R., & Achcar J. A. (2013).  Applications of Discrete-Time Markov Chains and Poisson Processes to Air Pollution Modeling and Studies.
Tribble, D. R., Baqar S., Scott D. A., Oplinger M. L., Trespalacios F., Rollins D., et al. (2010).  Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans. Infection and Immunity. 78, 4.
Kurtz, J.. B., Lee T.. W., Craig J.. W., & Reed S.. E. (1979).  Astrovirus infection in volunteers. Journal of medical virology. 3, 3.
C
Sjögren, E., Ruiz-Palacios G., & Kaijser B. (1989).  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes. Epidemiology & Infection. 102, 47–57.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical infectious diseases. 49, 1512–1519.
Tribble, D.. R., Baqar S.., Carmolli M.. P., Porter C.., Pierce K.. K., Sadigh K.., et al. (2009).  Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 49, 1512-1519.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Tribble, D. R., Baqar S., Carmolli M. P., Porter C., Pierce K. K., Sadigh K., et al. (2009).  Campylobacter jejuni Strain CG8421: A Refined Model for the Study of Campylobacteriosis and Evaluation of Campylobacter Vaccines in Human Subjects. Clinical Infectious Diseases. 49, 10.
Russell-Lodrigue, K.. E., Zhang G.. Q., McMurray D.. N., & Samuel J.. E. (2006).  Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever. Infection and Immunity. 74, 11.
Bédard, E., Boppe I., Kouamé S., Martin P., Pinsonneault L., Valiquette L., et al. (2016).  Combination of heat shock and enhanced thermal regime to control the growth of a persistent Legionella pneumophila strain. Pathogens. 5, 35.
Simpson, A.. J. H., Suputtamongkol Y.., Smith M.. D., Angus B.. J., Rajanuwong A.., Wuthiekanun V.., et al. (1999).  Comparison of Imipenem and Ceftazidime as Therapy for Severe Melioidosis. Clinical Infectious Diseases. 29, 2.
D
Njc, S., Doyle M.. P., Kasuga F.., Rotariu O.., & Ogden I.. D. (2005).  Dose response modelling of Escherichia coli O157 incorporating data from foodborne and environmental outbreaks. International Journal of Food Microbiology. 103, 1.
Murphy, B. R., Clements M. L., Madore H. P., Steinberg J., O'Donnell S., Betts R., et al. (1984).  Dose Response of Cold-Adapted, Reassortant Influenza A/California/10/78 Virus (H1N1) in Adult Volunteers. Journal of Infectious Diseases. 149, 5.
Smith, M. A., Takeuchi K., Anderson G., Ware G. O., McClure H. M., Raybourne R. B., et al. (2008).  Dose-Response Model for Listeria monocytogenes-Induced Stillbirths in Nonhuman Primates. Infection and Immunity. 76, 2.
Vesikari, T., Ruuska TARJA., Bogaerts HUGUES., Delem ANDRÉE., & André FRANCIS. (1985).  Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants.. Pediatric infectious disease. 4, 622–625.
E
Pichichero, M. E., Losonsky GENEVIEVE. A., Rennels MARGARET. B., Disney FRANK. A., Green JOHN. L., Francis ANNE. B., et al. (1990).  Effect of dose and a comparison of measures of vaccine take for oral rhesus rotavirus vaccine. The Maryland Clinical Studies Group.. The Pediatric infectious disease journal. 9, 339–344.
Lawin-Brüssel, C. A., Refojo M. F., Leong F. L., Hanninen L., & Kenyon K. R. (1993).  Effect of Pseudomonas aeruginosa concentration in experimental contact lens-related microbial keratitis. Cornea. 12, 1.
Diringer, H., Roehmel J., & Beekes M. (1998).  Effect of repeated oral infection of hamsters with scrapie. Journal of General Virology. 79,
Wong, M., Kumar L., Jenkins T. M., Xagoraraki I., Phanikumar M. S., & Rose J. B. (2009).  Evaluation of public health risks at recreational beaches in Lake Michigan via detection of enteric viruses and a human-specific bacteriological marker. Water research. 43, 1137–1149.